|
Patterns of care for patients with non-metastatic castration-resistant prostate cancer: Population-based study in Ontario, Canada. |
|
|
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Pharmaceuticals |
Travel, Accommodations, Expenses - Sanofi; Tersera |
|
|
Consulting or Advisory Role - Janssen Oncology |
|
|
|
Consulting or Advisory Role - Amgen; AstraZeneca Canada; Bayer; Bristol-Myers Squib; Celgene; Eisai; Ipsen; Ipsen; Janssen; Pfizer; Sanofi |
Speakers' Bureau - Amgen; Celgene; Janssen |
Research Funding - Sanofi |
|
|
Honoraria - Astellas Pharma; Eisai; Ipsen; Janssen; Merck; Pfizer |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer; Roche Canada |
|
|
Honoraria - Abbvie; Bayer; Ferring; Janssen |
|
|
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen |
Research Funding - Bayer; Janssen |
Travel, Accommodations, Expenses - Janssen |
|
|
Honoraria - Bayer; Bayer; Ipsen; Merck; Pfizer |
Consulting or Advisory Role - Bayer; Janssen; Janssen; Janssen; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pan-Canadian Oncology Drug Review (pCODR); Pfizer |
Travel, Accommodations, Expenses - Janssen |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Knight Pharmaceuticals; Merck; Novartis; Pfizer; Roche Canada |
Consulting or Advisory Role - AstraZeneca; Bayer; Merck; Novartis; Roche; Seagen |
Speakers' Bureau - AstraZeneca; Knight Therapeutics; Merck |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer; Bicycle Therapeutics (Inst); Immunomedics (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Zymeworks (Inst) |
Expert Testimony - Seattle Genetics/Astellas |
Travel, Accommodations, Expenses - Novartis; Roche |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; Janssen; Merck |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Ferring; Janssen; Merck |
Research Funding - Bayer; Janssen |
Expert Testimony - Janssen |
Travel, Accommodations, Expenses - Bayer; Janssen |
|
|
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Tersera |
|
|
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Knight Pharmaceuticals; Sanofi; TerSera; Verity Pharmaceuticals |
Consulting or Advisory Role - Janssen |
|
|
Stock and Other Ownership Interests - Knight Pharmaceuticals |
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Sanofi; Tersera |
Consulting or Advisory Role - Abbvie; AstraZeneca Canada; Bayer; Janssen Oncology; Sanofi; Tersera |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst); Tersera (Inst) |
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Janssen; Janssen Oncology; Merck; Merck; Pfizer; Pfizer; Roche Canada; Sanofi |
|
|
|
Stock and Other Ownership Interests - Myovant Sciences |
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi |
Speakers' Bureau - Astellas Pharma; Bayer; Janssen |
|
|
Honoraria - Astellas Scientific and Medical Affairs Inc; Bayer; Eisai; Ipsen; Janssen Oncology; Merck |
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Pfizer; Seagen |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SignalChem (Inst) |
Travel, Accommodations, Expenses - Eisai |
|
|
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi |
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi |
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst) |
|
|
|
|
|
No Relationships to Disclose |
|
|
|
|
|
Honoraria - Abbvie; Astellas Pharma; Bayer; Ferring; Janssen; Knight Pharmaceuticals; Merck; TerSera; Tolmar |